The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 30, 2022
Filed:
Sep. 13, 2019
Applicant:
Meharry Medical College, Nashville, TN (US);
Inventor:
Amosy M'Koma, Antioch, TN (US);
Assignee:
Other;
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6837 (2018.01); C12Q 1/6876 (2018.01); G01N 33/58 (2006.01); G01N 33/60 (2006.01); G01N 33/68 (2006.01); C12Q 1/6883 (2018.01); A61K 45/06 (2006.01); C12Q 1/37 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/37 (2013.01); C12Q 1/6837 (2013.01); C12Q 1/6876 (2013.01); C12Q 1/6883 (2013.01); G01N 33/582 (2013.01); G01N 33/60 (2013.01); G01N 33/68 (2013.01); A61K 45/06 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/8146 (2013.01); G01N 2800/065 (2013.01);
Abstract
Methods and materials are disclosed for testing biomarkers in a subject suffering from inflammatory bowel disease (IBD) are described herein. Such detection can be useful for diagnosing and treating ulcerative colitis (UC) and Crohn's disease (CD), two forms of IBD that are otherwise difficult to distinguish. The method includes measuring the level of one or more of several biomarkers, including HD5 or MMP-7, which are expressed differentially in patents with UC and CD. A treatment may be based on the determination of whether the subject has ulcerative colitis or Crohn's disease.